AI Article Synopsis
- The review focuses on how the cAMP signaling pathway influences the development of lymphoma and discusses possible therapeutic approaches targeting this pathway.
- Research primarily draws from studies published between 1995 and 2009 that examine the effects of cAMP on lymphoma cell apoptosis and the potential for targeted therapy.
- The findings suggest that the cAMP pathway can impact lymphoma prognosis, with cAMP analogues and PDE4B inhibitors showing promise for treatment, though challenges in fully understanding their effects persist.
Article Abstract
Objective: To review the role of cyclic adenosine monophosphate (cAMP) signal pathway in the pathogenesis of lymphoma and explore a potential lymphoma therapy targeted on this signaling pathway.
Data Sources: The data cited in this review were mainly obtained from the articles listed in Medline and PubMed, published from January 1995 to June 2009. The search terms were "cAMP" and "lymphoma".
Study Selection: Articles regarding the role of the cAMP pathway in apoptosis of lymphoma and associated cells and its potential role in targeted therapy of lymphoma.
Results: In the transformation of lymphocytic malignancies, several signal pathways are involved. Among of them, the cAMP pathway has attracted increasing attention because of its apoptosis-inducing role in several lymphoma cells. cAMP pathway impairment is found to influence the prognosis of lymphoma. Targeted therapy to the cAMP pathway seems to be a new direction for lymphoma treatment, aiming at restoring the cAMP function.
Conclusions: cAMP signal pathway has different effects on various lymphoma cells. cAMP analogues and phosphodiesterase 4B (PDE4B) inhibitors have potential clinical significance. However, many challenges remain in understanding the various roles of such agents.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!